Drugs in ATC Class A01A

Up to Top Level ATC Classes

Up to A - Alimentary tract and metabolism

Up to A01 - STOMATOLOGICAL PREPARATIONS

Subclasses in ATC: A01A - STOMATOLOGICAL PREPARATIONS

A01AA - Caries prophylactic agents

A01AB - Antiinfectives and antiseptics for local oral treatment

A01AC - Corticosteroids for local oral treatment

A01AD - Other agents for local oral treatment

Stomatological Preparations Market and Patent Landscape Analysis (ATC Class A01A)

Last updated: February 19, 2026

This report analyzes the patent landscape and market dynamics for stomatological preparations, categorized under the Anatomical Therapeutic Chemical (ATC) Classification System as A01A. The analysis focuses on key therapeutic areas, dominant patent holders, emerging trends, and regulatory considerations impacting R&D and investment in this sector.

What is the Scope of ATC Class A01A Stomatological Preparations?

ATC Class A01A encompasses drugs used for the prevention and treatment of oral and dental conditions. This includes a range of therapeutic categories, primarily focused on:

• Antiseptics and Disinfectants: Agents for reducing microbial load in the oral cavity, preventing infections, and aiding wound healing.
• Anti-inflammatory Agents: Medications to reduce inflammation of the gums, oral mucosa, and other oral tissues.
• Analgesics: Pain relievers for oral pain, including toothaches and post-procedural discomfort.
• Anticaries Agents: Substances aimed at preventing or reversing tooth decay, most notably fluoride compounds.
• Agents for Oral Mucosal Lesions: Treatments for conditions like aphthous ulcers, gingivitis, periodontitis, and dry mouth.
• Hemostatics: Agents to control bleeding in the oral cavity.
• Other Stomatological Preparations: Including agents for tooth desensitization and topical anesthetics.

The market for these preparations is driven by the prevalence of oral diseases, aging populations requiring specialized dental care, increased consumer awareness of oral hygiene, and advancements in therapeutic formulations.

What are the Key Therapeutic Areas within Stomatological Preparations?

The stomatological preparations market is segmented by the specific conditions they address. Key therapeutic areas include:

• Gingivitis and Periodontitis: Inflammatory conditions affecting the gums and supporting structures of the teeth. Products in this area often include antimicrobial agents, anti-inflammatory compounds, and agents promoting tissue regeneration.
• Dental Caries (Cavities): Tooth decay caused by bacterial acid production. Fluoride-based products, such as toothpastes and mouthwashes, are the primary interventions. Novel remineralization agents are also under development.
• Oral Mucosal Disorders: This broad category includes aphthous ulcers (canker sores), oral thrush (candidiasis), burning mouth syndrome, and chemotherapy-induced mucositis. Treatments involve antifungal agents, corticosteroids, topical anesthetics, and barrier-forming agents.
• Dry Mouth (Xerostomia): Reduced salivary flow, often a side effect of medications or radiation therapy. Saliva substitutes, stimulants, and protective agents are used.
• Tooth Sensitivity: Pain caused by exposed dentin, typically addressed by desensitizing toothpastes that block dentinal tubules.
• Post-Surgical and Post-Procedural Care: Products to aid healing and prevent infection after dental procedures like extractions, root canals, and periodontal surgery. These often include antiseptics and wound healing promoters.

Who are the Leading Patent Holders in Stomatological Preparations?

The patent landscape for stomatological preparations is characterized by a mix of large pharmaceutical companies, specialized dental product manufacturers, and academic institutions. Dominant patent holders often focus on specific niches or develop novel delivery systems for established active pharmaceutical ingredients (APIs). Key players and their areas of patent activity include:

• Colgate-Palmolive Company: Holds numerous patents related to toothpaste formulations, particularly concerning fluoride delivery, desensitizing agents (e.g., potassium nitrate, strontium chloride), and antimicrobial agents for gingivitis prevention. Their patents also cover novel formulations for oral hygiene products that enhance cleaning and long-term oral health.
• Procter & Gamble (P&G): A significant patent holder in oral care, with extensive intellectual property in areas such as whitening agents, remineralization technologies (including advanced fluoride formulations and calcium-based compounds), and formulations for sensitive teeth. P&G also patents delivery systems for antimicrobial agents and flavor technologies.
• 3M Company: Patents often relate to dental materials and adhesives used in restorative dentistry, but also extend to specialized stomatological preparations, including wound healing agents for oral surgical sites and therapeutic coatings.
• GlaxoSmithKline (GSK) Consumer Healthcare: Holds patents for over-the-counter (OTC) oral health products, including antiseptic mouthwashes, prescription-strength anti-gingivitis treatments, and formulations for managing oral thrush.
• Unilever PLC: Patents in this sector often focus on formulations for toothpaste and mouthwash, including active ingredients for cavity prevention, gum health, and breath freshening.
• Smaller Biotechnology and Specialty Pharmaceutical Companies: These entities often focus on niche areas, such as novel antimicrobials for resistant oral pathogens, advanced wound healing technologies for oral lesions, or specialized drug delivery systems for localized treatment of oral cancers or inflammatory diseases.

The trend is towards patents covering not just novel APIs, but also specific formulations, combinations of ingredients, manufacturing processes, and delivery mechanisms that enhance efficacy, patient compliance, and shelf-life.

What are the Emerging Trends in Stomatological Preparation Patents?

Several key trends are shaping patent filings and R&D investment in stomatological preparations:

• Biomimetic and Regenerative Therapies: A growing area of research focuses on stimulating natural oral tissue regeneration. Patents are emerging for scaffolds, growth factors, and cell-based therapies aimed at repairing damaged gums, bone, and dentin. This includes patented approaches for stimulating periodontal ligament regeneration and promoting dentinogenesis.
• Personalized Oral Care: Advancements in diagnostics and genetic profiling are leading to patents for tailored oral health solutions. This includes formulations designed for individuals with specific genetic predispositions to oral diseases or unique oral microbiome profiles.
• Novel Antimicrobial Strategies: With increasing concerns about antimicrobial resistance, patents are being filed for non-antibiotic antimicrobial agents, such as bacteriophages, antimicrobial peptides, and quorum sensing inhibitors, specifically designed for oral pathogens. This also includes combination therapies that enhance the efficacy of existing antimicrobials.
• Advanced Drug Delivery Systems: Innovation is focused on improving the targeted delivery and sustained release of active ingredients. Patents cover hydrogels, mucoadhesive films, nanoparticles, and microneedles for localized and prolonged therapeutic effects in the oral cavity, reducing systemic exposure and improving patient adherence.
• Focus on Oral Microbiome Modulation: A deeper understanding of the oral microbiome's role in health and disease is driving patenting activity around probiotics, prebiotics, and postbiotics designed to restore or maintain a healthy oral microbial balance. This includes patented formulations that selectively inhibit pathogenic bacteria while supporting beneficial ones.
• Sustained-Release Fluoride Technologies: Beyond traditional fluoride, patents are emerging for novel fluoride delivery systems and compounds that provide longer-lasting protection against demineralization and promote remineralization more effectively.
• Bioactive Compounds from Natural Sources: Research into natural products with therapeutic properties for oral health is leading to patents for extracts and isolated compounds from plants and microorganisms, focusing on anti-inflammatory, antioxidant, and antimicrobial activities.

What are the Key Regulatory Considerations for Stomatological Preparations?

Regulatory pathways for stomatological preparations vary depending on their classification, intended use, and marketing claims. Key considerations include:

• Classification as Drugs vs. Medical Devices vs. Cosmetics:

  • Drugs: Products intended to treat or prevent disease (e.g., prescription antibiotics for periodontal infections, prescription antifungals for oral thrush, FDA-approved fluoride treatments for high-risk caries patients). These require New Drug Applications (NDAs) or Abbreviated New Drug Applications (ANDAs) in the US, or Marketing Authorisation Applications (MAAs) in the EU.
  • Medical Devices: Products that achieve their primary intended action by other than pharmacological, metabolic, or immunological means (e.g., certain wound dressings, saliva substitutes that act as physical barriers, therapeutic mouthguards). These are regulated based on risk class and may require premarket notification (510(k)) or premarket approval (PMA) in the US.
  • Cosmetics: Products intended to cleanse, beautify, or alter appearance (e.g., most OTC toothpastes and mouthwashes with claims related to stain removal, breath freshening, or general oral hygiene). These are regulated under different frameworks with less stringent premarket review. Claims made must be substantiated and cannot be therapeutic.

• Premarket Approval (PMA) and 510(k) Process (US FDA): For medical devices and certain drugs, rigorous testing and documentation are required to demonstrate safety and efficacy before market entry.

• Marketing Authorisation Applications (MAA) (EU EMA): Similar to US drug approval, this involves comprehensive data submission on quality, safety, and efficacy.

• Good Manufacturing Practices (GMP): All products intended for human use must be manufactured under strict GMP guidelines to ensure quality, purity, and consistency.

• Labeling and Claims: Regulatory bodies scrutinize product labeling and marketing claims. Claims must be scientifically substantiated and align with the product's regulatory classification. Overly therapeutic claims for cosmetic products can lead to regulatory action.

• Adverse Event Reporting: Manufacturers are required to monitor and report adverse events associated with their products to regulatory authorities.

• Specific Ingredient Regulations: Regulations exist for certain active ingredients, such as fluoride concentration limits in OTC products and restrictions on the use of certain antibiotics or corticosteroids in non-prescription formulations.

• International Harmonization: While regulations vary by region, there is a growing trend towards international harmonization of regulatory standards, impacting data requirements and approval processes globally.

What are the Market Dynamics and Growth Drivers?

The market for stomatological preparations is influenced by several interconnected factors:

• Increasing Prevalence of Oral Diseases: Rising rates of periodontitis, dental caries, and oral cancer globally drive demand for preventive and therapeutic products. Factors include aging populations, dietary changes, and limited access to regular dental care in some regions.
• Growing Consumer Awareness and Demand for Oral Hygiene: Public health campaigns and increased access to information have elevated consumer awareness regarding the link between oral health and overall well-being. This fuels demand for advanced oral care products beyond basic cleaning.
• Aging Population: Older adults often experience a higher incidence of oral health issues, including dry mouth, periodontal disease, and tooth loss, increasing the need for specialized stomatological preparations.
• Technological Advancements: Innovations in formulations, delivery systems, and diagnostic tools enable the development of more effective and targeted treatments. This includes a shift towards personalized oral care solutions.
• Expansion of OTC Market: The availability of many effective stomatological preparations as over-the-counter products makes them more accessible to consumers, contributing to market growth.
• Oral Care in Systemic Disease Management: The recognized link between oral health and systemic conditions like diabetes, cardiovascular disease, and respiratory infections is leading to greater integration of oral hygiene and therapeutic interventions into broader healthcare strategies.
• Emerging Markets: Growing disposable incomes and increasing access to healthcare in developing countries are creating significant growth opportunities for oral care products.

Challenges include the high cost of R&D for novel therapies, stringent regulatory hurdles, and the competitive nature of the market, dominated by established players. Price sensitivity in some consumer segments also influences market dynamics.

Key Takeaways

The stomatological preparations market (ATC Class A01A) is driven by the significant global burden of oral diseases and increasing consumer demand for advanced oral hygiene. Patent activity is shifting from novel APIs to sophisticated formulations, biomimetic regenerative therapies, and microbiome-modulating agents. Key players like Colgate-Palmolive and P&G dominate through extensive IP portfolios in traditional areas like caries prevention and desensitization, while emerging trends focus on regenerative medicine and personalized oral care. Regulatory pathways are complex, distinguishing between drugs, medical devices, and cosmetics, with rigorous premarket review for therapeutic claims. Growth is fueled by an aging population, rising disease prevalence, and enhanced consumer awareness, alongside a trend towards integrating oral health into overall systemic health management.

FAQs

1. What is the most active therapeutic area in recent stomatological preparation patent filings? Recent patent filings show significant activity in novel antimicrobial strategies and advanced drug delivery systems, reflecting a response to antimicrobial resistance concerns and a drive for improved treatment efficacy and patient compliance. Biomimetic and regenerative therapies are also showing increased patenting activity.

2. How do regulatory classifications impact market entry for stomatological preparations? The classification as a drug, medical device, or cosmetic dictates the regulatory pathway. Drugs require extensive premarket approval demonstrating safety and efficacy for therapeutic claims, while cosmetics face lighter scrutiny with claims limited to aesthetic or cleansing benefits. Medical devices have specific risk-based approval processes. This significantly impacts development timelines, costs, and marketing strategies.

3. What role does the oral microbiome play in the future of stomatological preparations? The oral microbiome is emerging as a critical area. Patent filings are increasing for products that modulate this ecosystem, including probiotics, prebiotics, and selective antimicrobials. The goal is to shift the microbial balance towards a state that promotes health and prevents disease, moving beyond broad-spectrum disinfection.

4. Are there patent trends related to managing side effects of cancer therapies in the mouth? Yes, there is increasing interest and patenting activity around stomatological preparations designed to manage oral side effects of cancer therapies, such as chemotherapy-induced mucositis. This includes patents for specialized wound healing agents, pain management formulations, and barrier-forming products to protect oral mucosa.

5. What is the expected impact of personalized medicine on the stomatological preparation market? Personalized medicine is expected to drive demand for tailored stomatological preparations. Patents are anticipated for formulations that address an individual's specific oral microbiome, genetic predispositions to oral diseases, or unique physiological conditions like xerostomia exacerbated by specific medication regimens.

Citations

[1] World Health Organization. (2020). International Classification of Diseases (ICD-10-AM). Retrieved from https://www.who.int/standards/classifications/icd [2] U.S. Food and Drug Administration. (n.d.). Medical Devices. Retrieved from https://www.fda.gov/medical-devices [3] European Medicines Agency. (n.d.). How to apply for a medicines authorisation. Retrieved from https://www.ema.europa.eu/en/human-regulatory/marketing-authorisation [4] World Dental Federation. (n.d.). Oral Health and General Health. Retrieved from https://www.fdiworlddental.org/oral-health-and-general-health [5] Patent databases (e.g., USPTO, EPO, WIPO) searched for relevant patent filings related to stomatological preparations and ATC Class A01A. (Specific search parameters and date ranges applied in proprietary analysis).